We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein Receptor Recognizes Gram-Negative Bacteria

By Biotechdaily staff writers
Posted on 23 May 2002
Scientists have identified a cell surface receptor that enables macrophages to ingest and destroy gram-negative bacteria. More...
The researchers, from Massachusetts General Hospital (Boston, USA), found that inactivating a protein receptor called PGRP-LC destroyed the ability of macrophages to recognize and ingest E coli bacteria but not another type of bacteria called S aureus.

This suggests the protein is critical to the macrophage's specific response against gram-negative bacteria. The study appeared March 24, 2002, on the Internet as an advanced online publication of the journal Nature. It will be published in a future print edition of the journal.

In the current study, researchers studied macrophages from the fruit fly Drosophila. "The basic templates of how organisms protect themselves against infection go back millions of years in evolution, so we can learn lessons from flies that apply to humans,” says Dr. R. Alan Ezekowitz, the study's senior author. "In this study we look at a very ancient but very important process: how bacteria are recognized and eaten by immune cells called phagocytes (a group that includes macrophages).”

Using a new method of turning off specific genes, Dr. Ezekowitz's team identified 34 macrophage proteins that are essential to the process of phagocytosis. One of these proteins is a cell surface receptor called PGRP-LC. A group of Drosophila with a mutated version of PGRP-LC was found to be much more susceptible to E coli infection than were normal fruit flies.

"PGRP-LC represents a new class of recognition molecules, and there are very similar genes in humans,” Ezekowitz says. "The next question to ask is whether this protein plays a related role in humans. Understanding the role these proteins play could eventually lead to new ways of fighting infection and to helping us figure out why some people are more susceptible to specific infections.”




Related Links:
Massachusetts General Hospital

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.